Dupixent (dupilumab) is a brand-name injectable drug prescribed for asthma, eczema, and other inflammatory ... When you start Dupixent treatment, you and your doctor will discuss which form ...

Dupixent is a prescription medication that doctors prescribe for certain conditions, including asthma and eczema. It’s available as a subcutaneous injection. Injection site reactions ...

Still, many analysts on Wall Street think the correction is way overdone. Regeneron's stock could soar by 50% in the next ...

First approved in eczema in March 2017, Dupixent has since been approved in ... and newer branded drugs hit the market. Diabetes drug sales decreased 7% to 1.290 billion euros ($1.434 billion ...

Dupixent (dupilumab ... Biologics aren't usually a first-line treatment for eczema. This means that before starting one, your healthcare provider will want you to try other treatment options.

Sanofi’s Dupixent has shown there is a market for biologic drugs to treat eczema, and now Spain’s Almirall wants a piece of the action. The company’s head of external innovation and ...

A new class of medications referred to as JAK inhibitors ... Some examples of biologics that are used to treat eczema are Dupixent (dupilumab) or Ebglyss (lebrikizumab). Dupixent is FDA approved ...

Sanofi and Regeneron are in the process of testing out blockbuster biologic Dupixent ... s treatment demonstrated a “significantly greater least squares mean decrease” in their hand eczema ...

Eczema Support Australia managing ... wrote to Mr Butler and Sanofi urging them to ensure Dupixent remained on the PBS. When a medication is prescribed in higher numbers than anticipated under ...